Timing Is Everything: Implications for Metabolic Consequences of Sleep Restriction

Type 2 diabetes (T2D) is a complex disease driven by a combination of genetic and environmental factors. In recent years, several lines of evidence suggest that circadian disruption and sleep loss contribute to disease pathogenesis. Epidemiologic studies indicate that shift work is associated with an increased risk of T2D (1,2). Shift work is a prime example of circadian disruption, altering the timing of light exposure, meals, activity, and sleep. In many ways, the shift workers serve as early indicators, or “canaries in a coal mine,” of the long-term consequences of the circadian disruption experienced by a much broader segment of the population. A number of studies have concluded that genetic variation in melatonin receptors (notably expressed in pancreatic b-cells) is associated with impaired insulin secretion and increased risk for T2D (3,4). Similarly, genetic variation in the genes responsible for the generation of circadian rhythms has been linked to metabolic, endocrine, and behavioral changes that could push a patient toward development of T2D (5,6). This type of population study has been complimented by laboratory studies demonstrating that short duration of sleep adversely impacts glucose tolerance (7,8). More recently, laboratory studies where healthy participants were exposed to circadian misalignment using a forced desynchrony protocol provided causative evidence for a deleterious impact on diabetes risk and cardiovascular function (9,10). Sleep and circadian disruption have even been found to hinder the management of glycemic control in existing patients with T2D (11,12). The weight of these interconnections between disrupted sleep, circadian rhythms, and metabolic dysfunction has led Dr. E. Van Cauter and others to describe them as an “inseparable triad” (Fig. 1A). In this issue, Leproult et al. (13) seek to break apart this triad and distinguish between the relative importance of sleep and circadian disruption. In humans, sleep normally occurs during the night as body temperature is falling and melatonin secretion is high. As described above, previous work has shown that sleep restriction alone has negative consequences, but does the timing of the sleep make a difference? To look at this under controlled conditions, healthy young adults were examined after 4 days of sleep restriction (5 h per cycle) either with nocturnal bedtimes (circadian alignment) or with diurnal bedtimes (circadian misalignment). Daily total sleep time during the intervention was nearly identical in the aligned and misaligned conditions (just under 5 h). In both groups, insulin sensitivity and disposition index (an indicator of b-cell function) significantly decreased while inflammation increased after sleep restriction. In males, at least, exposure to circadian misalignment greatly enhanced both the reduction in insulin sensitivity and disposition index and the increase in inflammation. This difference between the sexes is intriguing and will need to be explored in future studies. The authors suggest that circadian misalignment that occurs in shift work may increase diabetes risk and inflammation, independently of sleep loss (Fig. 1B). The idea that circadian misalignment would increase the risk of diabetes and metabolic dysfunction fits well with clinical data and a large body of experimental evidence. For example, expression profiling has found that many of the genes involved in metabolism exhibit circadian rhythms in transcription, suggesting a close coupling between circadian rhythms and metabolism (14). Recent work indicates that these circadian clock genes provide a temporal